HCPCS Level IIdrugActive
J9301
Obinutuzumab inj
BETOS: O1D
Effective: 2015-01-01
Description
Injection, obinutuzumab, 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Gazyva
Manufacturer
Genentech, Inc.
HCPCS Dosage
10 MG
Billing Units
100.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.